Medicine
Posaconazole 300.6 mg/16.7 mL injection
Posaconazole 300.6 mg/16.7 mL injection is a generic prescription medicine for intravenous use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Storage conditions for the diluted solution are presented in another section…
Key facts
- Active ingredient (INN)
- Posaconazole
- Brand
- Sold under the generic name
- Strength
- 300.6 mg/16.7 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 16.7 mL and 5 more
- Manufacturers
- Glenmark PharmaceuticalsIndiaCamber PharmaceuticalsIndiaEugiaIndiaGland PharmaIndiaFresensius KabiMylan InstitutionalPar Health
- Origin register
- US FDA, United States
- Storage
- Storage conditions for the diluted solution are presented in another section of the prescribing information.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AC04 Posaconazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 January 2023
- Identifiers
- RxCUI 1492043DailyMed set ID 2e88e379-b712-4dec-97a2-c90ef3638372, 91f89a3b-2479-4d05-9997-7b0cfaa496ec, c551e121-d5fc-4b35-ba9f-72ce3a314fdc +5NDC 55150-388, 68462-911, 31722-370 +5Application ANDA214842, ANDA217553, ANDA219057 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 16.7 mL in 1 vial | 68462-904-01 | Glenmark PharmaceuticalsIndia | 27 December 2023 |
| 1 vial in 1 carton / 16.7 mL in 1 vial | 68462-911-01 | Glenmark PharmaceuticalsIndia | 1 July 2024 |
| 1 vial, glass in 1 carton / 16.7 mL in 1 vial, glass | 31722-370-31 | Camber PharmaceuticalsIndia | 23 December 2024 |
| 1 vial, single-dose in 1 carton / 16.7 mL in 1 vial, single-dose | 55150-388-01 | EugiaIndia | 26 December 2023 |
| 1 vial in 1 carton / 16.7 mL in 1 vial | 68083-577-01 | Gland PharmaIndia | 26 December 2023 |
| 1 vial, single-dose in 1 carton / 16.7 mL in 1 vial, single-dose | 63323-685-17 | Fresensius Kabi | 26 December 2023 |
| 1 vial, glass in 1 carton / 16.7 mL in 1 vial, glass | 67457-665-20 | Mylan Institutional | 22 March 2024 |
| 1 vial, glass in 1 carton / 16.7 mL in 1 vial, glass | 42023-195-01 | Par Health | 1 January 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Posaconazole 300.6 mg/16.7 mL injection.
Other strengths and forms of Posaconazole
Clinical summary
Posaconazole is an azole antifungal indicated as follows, among other approved uses. It is available as delayed-release tablets, injection and tablets for oral and intravenous use. MedsAcross supplies Posaconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PosaconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- POSACONAZOLE prescribing information (Endo) · U.S. National Library of Medicine, DailyMed
- Noxafil: European public assessment report (EPAR) · European Medicines Agency
- Posaconazole Accord: European public assessment report (EPAR) · European Medicines Agency
Need Posaconazole 300.6 mg/16.7 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.